SCOPUS 정보 검색 플랫폼

World Journal of Surgery

Volumn 24, Issue 11, 2000, Pages 1285-1289

Nuclear medicine applications for neuroendocrine tumors

(5) Chatal, J F a Le Bodic, M F b Kraeber Bodere F a Rousseau, C a Resche, I a

a CENTRE RENÉ GAUDUCHEAU (France)

b Service d'Anatomie Pathologique (France)

Author keywords

[No Author keywords available]

Indexed keywords

(3 IODOBENZYL)GUANIDINE; (3 IODOBENZYL)GUANIDINE I 131; INDIUM 111; OCTREOTIDE; RADIOPHARMACEUTICAL AGENT; YTTRIUM 90;

CARCINOID; CONFERENCE PAPER; HUMAN; ISOTOPE LABELING; METASTASIS; NEUROENDOCRINE TUMOR; NONHUMAN; PHEOCHROMOCYTOMA; SCINTIGRAPHY;

3-IODOBENZYLGUANIDINE; CARCINOID TUMOR; FEMALE; HUMANS; MALE; NEUROENDOCRINE TUMORS; NUCLEAR MEDICINE; OCTREOTIDE; PHEOCHROMOCYTOMA; PROGNOSIS; RADIOIMMUNOTHERAPY; RADIOPHARMACEUTICALS; SENSITIVITY AND SPECIFICITY; THYROID NEOPLASMS;

EID: 0033769741 PISSN: 03642313 EISSN: None Source Type: Journal
DOI: 10.1007/s002680010213 Document Type: Conference Paper

Times cited : (46)

References (9)

1
- 0028929389
- Revised classification of neuroendocrine tumours of the lung, pancreas and gut
- (1995) Virchows Arch , vol.425 , pp. 547
- Capella, C.¹ Heitz, P.H.² Hofler, H.³ Solcia, E.⁴ Kloppel, G.⁵

2
- 4244207366
- Neuroendocrine tumors
- Nuclear Oncology, Aktolun, C., Tauxe, W.N., editors, Tokyo, Springer
- (1998) , pp. 1-31
- Shapiro, B.¹ Fig, L.M.² Gross, M.D.³ Shulkin, M.D.⁴ Sisson, J.C.⁵

3
- 0003129756
- Peptide receptor scintigraphy in oncology
- Nuclear Medicine in Clinical Diagnosis and Treatment, 2nd edition, Murray, I.P.C., Ell, P.J., editors, Edinburgh, Churchill Livingstone
- (1998) , pp. 859-870
- Krenning, E.P.¹ Kwekkeboom, D.J.² Reubi, J.C.³

4
- 0031843687
- The somatostatin receptor-targeted radiotherapeutic [Y-90-DOTA-DPhe(1), Tyr(3)]octreotide (Y-90-SMT 487) eradicates experimental rat pancreatic CA 20948 tumours
- (1998) Eur. J. Nucl. Med. , vol.25 , pp. 668
- Stolz, B.¹ Weckbecker, G.² Smith-Jones, P.³ Rainer, A.⁴ Rault, F.⁵ Bruns, C.⁶

5
- 0033396445
- 3-octreotide: Preliminary report in cancer patients
- (1999) Cancer Biother. Radiopharmacol. , vol.14 , pp. 477
- Paganelli, P.¹ Zoboli, S.² Cremonesi, H.R.³ Chinol, M.⁴

6
- 0030163020
- Radio-immunotherapy of medullary thyroid cancer with iodine-131-labeled anti-CEA antibodies
- (1996) J. Nucl. Med. , vol.37 , pp. 37
- Juweid, M.¹ Sharkey Behr, T.² Swayne, L.C.³ Herskovic, T.⁴ Pereira, M.⁵ Rubin, A.⁶ Hanley, D.⁷ Dunn, R.⁸ Siegel, J.⁹ Goldenberg, D.M.¹⁰

7
- 0032719527
- Radio-immunotherapy in medullary thyroid cancer using bispecific antibody and iodine 131-labeled bivalent hapten: Preliminary results of a phase I/II clinical trial
- (1999) Clin. Cancer Res. , vol.5
- Kraeber-Bodere, F.¹ Bardet, S.² Hoefnagel, C.A.³ Vieira, M.R.⁴ Vuillez, J.P.⁵ Murat, A.⁶ Ferreira, T.C.⁷ Bardies, M.⁸ Ferrer, L.⁹ Resche, I.¹⁰ Gautherot, E.¹¹ Rouvier, E.¹² Barbet, J.¹³ Chatal, J.C.¹⁴

8
- 14444275786
- Improved treatment of medullary thyroid cancer in a nude mouse model by combined radioimmunotherapy: Doxorubicin potentiates the therapeutic efficacy of radiolabeled antibodies in a radioresistant tumor type
- (1997) Cancer Res. , vol.57 , pp. 5309
- Behr, T.M.¹ Wults, E.² Radetzky, S.³ Blumenthal, R.D.⁴ Dunn, R.M.⁵ Gratz, S.⁶ Rave-Frak, M.⁷ Schmidberger, H.⁸ Raue, F.⁹ Becker, W.¹⁰

9
- 0030933299
- Synergy of Taxol and radioimmunotherapy with yttrium-90-labeled chimeric L6 antibody: Efficacy and toxicity in breast cancer xenografts
- (1997) Proc. Natl. Acad. Sci. U.S.A. , vol.94 , pp. 4000
- DeNardo, S.J.¹ Kukis, D.L.² Kroger, L.A.³ O'Donnell, R.T.⁴ Lamborn, K.R.⁵ DeNardo, D.G.⁶ Meares, C.F.⁷ DeNardo, G.L.⁸

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.